Connection

Co-Authors

This is a "connection" page, showing publications co-authored by CHERYL F HIRSCH-GINSBERG and HAGOP M KANTARJIAN.
Connection Strength

0.194
  1. Quantification of the breakpoint cluster region rearrangement for clinical monitoring in Philadelphia chromosome-positive chronic myeloid leukemia. Blood. 1995 May 15; 85(10):2705-10.
    View in: PubMed
    Score: 0.032
  2. "T-cell-rich B-cell lymphoproliferative disorder" of the bone marrow. Leuk Lymphoma. 2001 Sep-Oct; 42(5):1023-31.
    View in: PubMed
    Score: 0.025
  3. RAS mutations are rare events in Philadelphia chromosome-negative/bcr gene rearrangement-negative chronic myelogenous leukemia, but are prevalent in chronic myelomonocytic leukemia. Blood. 1990 Sep 15; 76(6):1214-9.
    View in: PubMed
    Score: 0.023
  4. Mixed-lineage leukemia revisited: acute lymphocytic leukemia with myeloperoxidase-positive blasts by electron microscopy. Blood. 1990 Aug 15; 76(4):808-13.
    View in: PubMed
    Score: 0.023
  5. Preliminary results of treatment with filgrastim for relapse of leukemia and myelodysplasia after allogeneic bone marrow transplantation. N Engl J Med. 1993 Sep 09; 329(11):757-61.
    View in: PubMed
    Score: 0.014
  6. Use of peripheral blood blasts vs bone marrow blasts for diagnosis of acute leukemia. Am J Clin Pathol. 1999 Jun; 111(6):733-40.
    View in: PubMed
    Score: 0.011
  7. Role of granulocyte-macrophage colony-stimulating factor in Philadelphia (Ph1)-positive acute lymphoblastic leukemia: studies on two newly established Ph1-positive acute lymphoblastic leukemia cell lines (Z-119 and Z-181). J Cell Physiol. 1996 Mar; 166(3):618-30.
    View in: PubMed
    Score: 0.008
  8. CD8-depleted donor lymphocyte infusion as treatment for relapsed chronic myelogenous leukemia after allogeneic bone marrow transplantation. Blood. 1995 Dec 01; 86(11):4337-43.
    View in: PubMed
    Score: 0.008
  9. The breakpoint cluster region site in patients with Philadelphia chromosome-positive chronic myelogenous leukemia. Clinical, laboratory, and prognostic correlations. Cancer. 1995 Sep 15; 76(6):992-7.
    View in: PubMed
    Score: 0.008
  10. All-trans retinoic acid followed by chemotherapy for salvage of refractory or relapsed acute promyelocytic leukemia. Cancer. 1994 Jun 15; 73(12):2946-52.
    View in: PubMed
    Score: 0.008
  11. Characteristics and outcome of patients with acute lymphocytic leukemia and myeloperoxidase-positive blasts by electron microscopy. Hematol Pathol. 1994; 8(4):155-67.
    View in: PubMed
    Score: 0.007
  12. Richter's syndrome: a report on 39 patients. J Clin Oncol. 1993 Oct; 11(10):1985-9.
    View in: PubMed
    Score: 0.007
  13. Response assessment in chronic lymphocytic leukemia after fludarabine plus prednisone: clinical, pathologic, immunophenotypic, and molecular analysis. Blood. 1992 Jul 01; 80(1):29-36.
    View in: PubMed
    Score: 0.007
  14. Treatment of hairy cell leukemia with 2-chlorodeoxyadenosine (2-CdA). Blood. 1992 Feb 15; 79(4):882-7.
    View in: PubMed
    Score: 0.006
  15. Strategy for breakpoint cluster region analysis in chronic myelocytic leukemia in a routine clinical laboratory. Am J Clin Pathol. 1990 Dec; 94(6):762-7.
    View in: PubMed
    Score: 0.006
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.